Pages that link to "Q41723159"

The following pages link to The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase (Q41723159):

Displaying 19 items.

• Overexpression of a truncated human topoisomerase III partially corrects multiple aspects of the ataxia-telangiectasia phenotype (Q24679218) (← links)
• Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation (Q33189233) (← links)
• Cyclophosphamide, ara-C and topotecan (CAT) for patients with refractory or relapsed acute leukemia (Q40622456) (← links)
• Biological basis for chemo-radiotherapy interactions (Q40665228) (← links)
• Evaluation of cell survival, DNA double strand breaks, and DNA synthesis during concurrent camptothecin and X-radiation treatments (Q40777344) (← links)
• The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: report of a synergistic effect between topotecan and radiation (Q41163169) (← links)
• Reduction of etoposide induced cell killing by hyperthermia can occur without changes in etoposide transport or DNA topoisomerase II activity (Q41186758) (← links)
• Radiation lethality enhancement with 9-aminocamptothecin: comparison to other topoisomerase I inhibitors (Q41189151) (← links)
• Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines (Q41456758) (← links)
• DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells (Q41622536) (← links)
• Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells. (Q43878334) (← links)
• Combined modality treatment using BID radiation for locally advanced non-small cell lung carcinoma (Q44824198) (← links)
• Effects of topoisomerase I-targeted drugs on radiation response of L5178Y sublines differentially radiation and drug sensitive (Q49169591) (← links)
• Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts. (Q55384068) (← links)
• Topoisomerase I activity and cellular response to radiation in Chinese hamster cells (Q71518308) (← links)
• Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation (Q71727512) (← links)
• SN-38, a metabolite of the camptothecin derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids (Q73437187) (← links)
• Preclinical evaluation of the orally active camptothecin analog, RFS-2000 (9-nitro-20(S)-camptothecin) as a radiation enhancer (Q73764983) (← links)
• Effects of SN-38 (an active metabolite of CPT-11) on responses of human and rodent cells to irradiation (Q77654059) (← links)